Carina Biotech submits an Investigational New Drug (IND) application to the US FDA for LGR5-Targeted CAR-T Cell Therapy Candidate
Carina Biotech files its first IND application for a CAR-T cell therapy targeting a solid cancer. The IND application is directed at a first-in-human Phase 1/2a clinical trial in advanced